270 related articles for article (PubMed ID: 26875521)
1. Management of Familial Hypercholesterolemia in Hong Kong.
Hu M; Hooper AJ; Bockxmeer FM; Watts GF; Chan JC; Tomlinson B
J Atheroscler Thromb; 2016 May; 23(5):520-31. PubMed ID: 26875521
[TBL] [Abstract][Full Text] [Related]
2. My Approach to the Patient With Familial Hypercholesterolemia.
Safarova MS; Kullo IJ
Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
[TBL] [Abstract][Full Text] [Related]
3. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases.
Hu M; Lan W; Lam CW; Mak YT; Pang CP; Tomlinson B
Int J Cardiol; 2013 Aug; 167(3):762-7. PubMed ID: 22464486
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
7. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.
Blom DJ; Almahmeed W; Al-Rasadi K; Azuri J; Daclin V; Kayikcioglu M; Mercier F; Ruiz AJ; Santos RD;
J Clin Lipidol; 2019; 13(4):594-600. PubMed ID: 31208705
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
[TBL] [Abstract][Full Text] [Related]
10. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
11. Progress in the care of familial hypercholesterolaemia: 2016.
Bell DA; Watts GF
Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
[TBL] [Abstract][Full Text] [Related]
12. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
Sinan ÜY; Sansoy V
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
[TBL] [Abstract][Full Text] [Related]
13. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
14. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice.
Catapano AL; Lautsch D; Tokgözoglu L; Ferrieres J; Horack M; Farnier M; Toth PP; Brudi P; Tomassini JE; Ambegaonkar B; Gitt AK
Atherosclerosis; 2016 Sep; 252():1-8. PubMed ID: 27494444
[TBL] [Abstract][Full Text] [Related]
16. Familial hypercholesterolemia.
Sawhney JPS; Madan K
Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S108-S112. PubMed ID: 38599725
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
[TBL] [Abstract][Full Text] [Related]
18. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
Knickelbine T; Lui M; Garberich R; Miedema MD; Strauss C; VanWormer JJ
J Clin Lipidol; 2016; 10(5):1182-7. PubMed ID: 27678435
[TBL] [Abstract][Full Text] [Related]
19. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
Vuorio A; Kovanen PT
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
[TBL] [Abstract][Full Text] [Related]
20. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
Stein EA; Gipe D; Bergeron J; Gaudet D; Weiss R; Dufour R; Wu R; Pordy R
Lancet; 2012 Jul; 380(9836):29-36. PubMed ID: 22633824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]